Over the past 12‑18 months the Radiation Protection Surgical Gloves industry has seen a wave of activity that reshapes its competitive landscape. In March 2024, MedShield Technologies entered a strategic partnership with EuroSafe Instruments to co‑develop a graphene‑infused glove line that promises a 30 % reduction in dose transmission while maintaining tactile sensitivity. The same month, GlobalGuard Ltd. completed its acquisition of RadiantGlove GmbH, expanding its European footprint and adding a patented lead‑free polymer to its portfolio. In July 2024, SterilePro announced a product launch of the “ClearGuard” series, a transparent, single‑use glove incorporating nano‑ceramic shielding, which quickly gained FDA clearance under the updated 2023 Radiation Safety Guidance. Regulatory momentum continued when the European Commission amended the Medical Device Regulation (MDR) in September 2024, mandating quantitative dose‑reduction testing for all surgical gloves marketed for radiological procedures. Meanwhile, venture capital funding surged, with a $45 million Series B round led by HealthTech Ventures fueling SafeTouch Inc.’s expansion into Asian markets. These moves collectively illustrate the accelerating Radiation Protection Surgical Gloves industry trends toward advanced materials, tighter compliance, and global consolidation.
